Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandro Cozzi Lepri

Showing results (211-220 of 227) with videos related to

Pageof 23
Sort By:
Antiviral Therapy|April 13, 2019
Very high pre-therapy viral load is a predictor of virological rebound in HIV-1-infected patients starting a modern first-line regimenDaniele Armenia, Domenico Di Carlo, Alessandro Cozzi-Lepri, et al.
The Journal of Antimicrobial Chemotherapy|January 31, 2016
Improved darunavir genotypic mutation score predicting treatment response for patients infected with HIV-1 subtype B and non-subtype B receiving a salvage regimenAndrea De Luca, Philippe Flandre, David Dunn, et al.
Frontiers in Medicine|March 26, 2024
Development and validation of a prediction score for failure to casirivimab/imdevimab in hospitalized patients with COVID-19 pneumoniaAlessandro Cozzi-Lepri, Vanni Borghi, Salvatore Rotundo, et al.
Science (New York, N.Y.)|July 21, 2007
A whole-genome association study of major determinants for host control of HIV-1Jacques Fellay, Kevin V Shianna, Dongliang Ge, et al.
The Lancet. Infectious Diseases|March 1, 2011
Effect of transmitted drug resistance on virological and immunological response to initial combination antiretroviral therapy for HIV (EuroCoord-CHAIN joint project): a European multicohort studyLinda Wittkop, Huldrych F Günthard, Frank de Wolf, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 2, 2022
Humoral and Cellular Immune Response Elicited by mRNA Vaccination Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in People Living With Human Immunodeficiency Virus Receiving Antiretroviral Therapy Based on Current CD4 T-Lymphocyte CountAndrea Antinori, Stefania Cicalini, Silvia Meschi, et al.
Microorganisms|September 28, 2021
Herpes Simplex Virus Re-Activation in Patients with SARS-CoV-2 Pneumonia: A Prospective, Observational StudyErica Franceschini, Alessandro Cozzi-Lepri, Antonella Santoro, et al.
Critical Care Medicine|December 11, 2014
Invasive Candida infections and the harm from antibacterial drugs in critically ill patients: data from a randomized, controlled trial to determine the role of ciprofloxacin, piperacillin-tazobactam, meropenem, and cefuroximeJens-Ulrik S Jensen, Lars Hein, Bettina Lundgren, et al.
Vaccines|November 25, 2023
SARS-CoV-2 mRNA Vaccine Response in People Living with HIV According to CD4 Count and CD4/CD8 RatioAlessandra Vergori, Alessandro Tavelli, Giulia Matusali, et al.
The Lancet. Respiratory Medicine|January 13, 2018
Induced hypothermia in patients with septic shock and respiratory failure (CASS): a randomised, controlled, open-label trialTheis Skovsgaard Itenov, Maria Egede Johansen, Morten Bestle, et al.
Pageof 23

Showing results (211-220 of 227) with videos related to

Sort By:
Pageof 23
Antiviral Therapy|April 13, 2019
Very high pre-therapy viral load is a predictor of virological rebound in HIV-1-infected patients starting a modern first-line regimenDaniele Armenia, Domenico Di Carlo, Alessandro Cozzi-Lepri, et al.
The Journal of Antimicrobial Chemotherapy|January 31, 2016
Improved darunavir genotypic mutation score predicting treatment response for patients infected with HIV-1 subtype B and non-subtype B receiving a salvage regimenAndrea De Luca, Philippe Flandre, David Dunn, et al.
Frontiers in Medicine|March 26, 2024
Development and validation of a prediction score for failure to casirivimab/imdevimab in hospitalized patients with COVID-19 pneumoniaAlessandro Cozzi-Lepri, Vanni Borghi, Salvatore Rotundo, et al.
Science (New York, N.Y.)|July 21, 2007
A whole-genome association study of major determinants for host control of HIV-1Jacques Fellay, Kevin V Shianna, Dongliang Ge, et al.
The Lancet. Infectious Diseases|March 1, 2011
Effect of transmitted drug resistance on virological and immunological response to initial combination antiretroviral therapy for HIV (EuroCoord-CHAIN joint project): a European multicohort studyLinda Wittkop, Huldrych F Günthard, Frank de Wolf, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 2, 2022
Humoral and Cellular Immune Response Elicited by mRNA Vaccination Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in People Living With Human Immunodeficiency Virus Receiving Antiretroviral Therapy Based on Current CD4 T-Lymphocyte CountAndrea Antinori, Stefania Cicalini, Silvia Meschi, et al.
Microorganisms|September 28, 2021
Herpes Simplex Virus Re-Activation in Patients with SARS-CoV-2 Pneumonia: A Prospective, Observational StudyErica Franceschini, Alessandro Cozzi-Lepri, Antonella Santoro, et al.
Critical Care Medicine|December 11, 2014
Invasive Candida infections and the harm from antibacterial drugs in critically ill patients: data from a randomized, controlled trial to determine the role of ciprofloxacin, piperacillin-tazobactam, meropenem, and cefuroximeJens-Ulrik S Jensen, Lars Hein, Bettina Lundgren, et al.
Vaccines|November 25, 2023
SARS-CoV-2 mRNA Vaccine Response in People Living with HIV According to CD4 Count and CD4/CD8 RatioAlessandra Vergori, Alessandro Tavelli, Giulia Matusali, et al.
The Lancet. Respiratory Medicine|January 13, 2018
Induced hypothermia in patients with septic shock and respiratory failure (CASS): a randomised, controlled, open-label trialTheis Skovsgaard Itenov, Maria Egede Johansen, Morten Bestle, et al.
Pageof 23